3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Genetics -

Study finds gene links to common lymphoma cancer

Cancer • • GeneticsNov 01, 10

Scientists have found three new gene variations linked to the development of Hodgkin lymphoma, one of the most common cancers in young adults, and say the findings should help in the development of better treatments.

Around a quarter to half of all cases of Hodgkin lymphoma, a type of cancer originating from white blood cells called lymphocytes, are thought to be triggered by infection with Epstein-Barr virus (EBV), but the disease can also develop in patients who have never been exposed to the virus.

Scientists had suspected genetic factors might be involved, since having a family history of the disease increases risk, but until now they had not been able to identify any specific genetic risk factors.

In a study published in the journal Nature Genetics on Sunday, an international team of scientists found three new variations in the letters of the DNA code that give an increased risk of developing Hodgkin lymphoma. Two of the variants are more common in people not exposed to EBV, they said.

Epstein-Barr virus is a very infectious type of herpes virus that can cause a number of diseases ranging from mild cold-like symptoms to glandular fever and potentially other autoimmune disorders.

“Many cases of Hodgkin lymphoma are linked to Epstein-Barr virus, but we have found the first evidence of genes that could be involved in promoting this cancer’s development in people not exposed to the virus,” said Professor Richard Houlston of the Institute of Cancer Research (ICR), who led the study.

“Understanding the biological triggers for Hodgkin lymphoma is crucial as it opens the door to creating new targeted therapies for this disease.”

Latest data from the International Agency for Research on Cancer show almost 68,000 people worldwide were diagnosed with Hodgkin lymphoma in 2008. The global death rate from this cancer is around 21,700 a year.

Houlston’s team used a technique called a genome wide association study to scan the whole genomes of 589 Hodgkin lymphoma patients and compare the results to 5,199 people without the disease. They then confirmed the results by analyzing another 5,400 people.

They found genetic variants on chromosomes 2, 8 and 10 were significantly more common among Hodgkin lymphoma sufferers than in those without the disease.

They also found that a region on chromosome 6 - which contains a family of genes involved in the immune system - is linked to a higher risk of disease, a finding the scientists said had previously been suspected but not confirmed until now.

SOURCE:  Nature Genetics, online October 31, 2010.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  Massively parallel gene function assays aim to reduce uncertainty of genetic diagnoses
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site